GlassScriptPhysician profile
Jean I Keddissi
NPI 1568430718
$4,229.04
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $126 · 2022: $3,616.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,616.29 | 2022 | |
| Allergan, INC. | $215.86 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $128.05 | 2019-2020 | |
| Genentech USA, INC. | $99.46 | 2019 | |
| Glaxosmithkline, LLC. | $72.78 | 2019 | |
| Merck Sharp & Dohme LLC | $28.58 | 2020 | |
| Vifor Pharma, INC. | $19.97 | 2019 | |
| Insmed, INC. | $18.23 | 2020 | |
| Edwards Lifesciences Corporation | $18.22 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.60 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Keddissi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.